Literature DB >> 16400611

Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample.

Brian K Suarez1, Jubao Duan, Alan R Sanders, Anthony L Hinrichs, Carol H Jin, Cuiping Hou, Nancy G Buccola, Nancy Hale, Ann N Weilbaecher, Deborah A Nertney, Ann Olincy, Susan Green, Arthur W Schaffer, Christopher J Smith, Dominique E Hannah, John P Rice, Nancy J Cox, Maria Martinez, Bryan J Mowry, Farooq Amin, Jeremy M Silverman, Donald W Black, William F Byerley, Raymond R Crowe, Robert Freedman, C Robert Cloninger, Douglas F Levinson, Pablo V Gejman.   

Abstract

We report the clinical characteristics of a schizophrenia sample of 409 pedigrees--263 of European ancestry (EA) and 146 of African American ancestry (AA)--together with the results of a genome scan (with a simple tandem repeat polymorphism interval of 9 cM) and follow-up fine mapping. A family was required to have a proband with schizophrenia (SZ) and one or more siblings of the proband with SZ or schizoaffective disorder. Linkage analyses included 403 independent full-sibling affected sibling pairs (ASPs) (279 EA and 124 AA) and 100 all-possible half-sibling ASPs (15 EA and 85 AA). Nonparametric multipoint linkage analysis of all families detected two regions with suggestive evidence of linkage at 8p23.3-q12 and 11p11.2-q22.3 (empirical Z likelihood-ratio score [Z(lr)] threshold >/=2.65) and, in exploratory analyses, two other regions at 4p16.1-p15.32 in AA families and at 5p14.3-q11.2 in EA families. The most significant linkage peak was in chromosome 8p; its signal was mainly driven by the EA families. Z(lr) scores >2.0 in 8p were observed from 30.7 cM to 61.7 cM (Center for Inherited Disease Research map locations). The maximum evidence in the full sample was a multipoint Z(lr) of 3.25 (equivalent Kong-Cox LOD of 2.30) near D8S1771 (at 52 cM); there appeared to be two peaks, both telomeric to neuregulin 1 (NRG1). There is a paracentric inversion common in EA individuals within this region, the effect of which on the linkage evidence remains unknown in this and in other previously analyzed samples. Fine mapping of 8p did not significantly alter the significance or length of the peak. We also performed fine mapping of 4p16.3-p15.2, 5p15.2-q13.3, 10p15.3-p14, 10q25.3-q26.3, and 11p13-q23.3. The highest increase in Z(lr) scores was observed for 5p14.1-q12.1, where the maximum Z(lr) increased from 2.77 initially to 3.80 after fine mapping in the EA families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400611      PMCID: PMC1380238          DOI: 10.1086/500272

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  72 in total

1.  Complex low-copy repeats associated with a common polymorphic inversion at human chromosome 8p23.

Authors:  Hirobumi Sugawara; Naoki Harada; Tomoko Ida; Takafumi Ishida; David H Ledbetter; Ko-ichiro Yoshiura; Tohru Ohta; Tatsuya Kishino; Norio Niikawa; Naomichi Matsumoto
Journal:  Genomics       Date:  2003-08       Impact factor: 5.736

2.  A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set.

Authors:  Tara C Matise; Ravi Sachidanandam; Andrew G Clark; Leonid Kruglyak; Ellen Wijsman; Jerzy Kakol; Steven Buyske; Buena Chui; Patrick Cohen; Claudia de Toma; Margaret Ehm; Stephen Glanowski; Chunsheng He; Jeremy Heil; Kyriacos Markianos; Ivy McMullen; Margaret A Pericak-Vance; Arkadiy Silbergleit; Lincoln Stein; Michael Wagner; Alexander F Wilson; Jeffrey D Winick; Emily S Winn-Deen; Carl T Yamashiro; Howard M Cann; Eric Lai; Arthur L Holden
Journal:  Am J Hum Genet       Date:  2003-07-03       Impact factor: 11.025

3.  Ignoring linkage disequilibrium among tightly linked markers induces false-positive evidence of linkage for affected sib pair analysis.

Authors:  Qiqing Huang; Sanjay Shete; Christopher I Amos
Journal:  Am J Hum Genet       Date:  2004-10-18       Impact factor: 11.025

4.  A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder.

Authors:  E S Gershon; L E DeLisi; J Hamovit; J I Nurnberger; M E Maxwell; J Schreiber; D Dauphinais; C W Dingman; J J Guroff
Journal:  Arch Gen Psychiatry       Date:  1988-04

5.  Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit.

Authors:  David J Gerber; Diana Hall; Tsuyoshi Miyakawa; Sandra Demars; Joseph A Gogos; Maria Karayiorgou; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

6.  Prevalence and correlates of self-reported psychotic symptoms in the British population.

Authors:  Louise C Johns; Mary Cannon; Nicola Singleton; Robin M Murray; Michael Farrell; Traolach Brugha; Paul Bebbington; Rachel Jenkins; Howard Meltzer
Journal:  Br J Psychiatry       Date:  2004-10       Impact factor: 9.319

7.  The Roscommon Family Study. II. The risk of nonschizophrenic nonaffective psychoses in relatives.

Authors:  K S Kendler; M McGuire; A M Gruenberg; M Spellman; A O'Hare; D Walsh
Journal:  Arch Gen Psychiatry       Date:  1993-08

8.  The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives.

Authors:  K S Kendler; M McGuire; A M Gruenberg; A O'Hare; M Spellman; D Walsh
Journal:  Arch Gen Psychiatry       Date:  1993-07

Review 9.  The molecular genetics of schizophrenia: new findings promise new insights.

Authors:  M J Owen; N M Williams; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2004-01       Impact factor: 15.992

10.  Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q.

Authors:  Peter Holmans; George S Zubenko; Raymond R Crowe; J Raymond DePaulo; William A Scheftner; Myrna M Weissman; Wendy N Zubenko; Sandra Boutelle; Kathleen Murphy-Eberenz; Dean MacKinnon; Melvin G McInnis; Diana H Marta; Philip Adams; James A Knowles; Madeleine Gladis; Jo Thomas; Jennifer Chellis; Erin Miller; Douglas F Levinson
Journal:  Am J Hum Genet       Date:  2004-04-22       Impact factor: 11.025

View more
  52 in total

1.  Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Authors:  Kristin K Nicodemus; Amanda J Law; Eugenia Radulescu; Augustin Luna; Bhaskar Kolachana; Radhakrishna Vakkalanka; Dan Rujescu; Ina Giegling; Richard E Straub; Kate McGee; Bert Gold; Michael Dean; Pierandrea Muglia; Joseph H Callicott; Hao-Yang Tan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent.

Authors:  Irina N Bespalova; Gary W Angelo; Ben P Ritter; Jason Hunter; Maria L Reyes-Rabanillo; Larry J Siever; Jeremy M Silverman
Journal:  Neuromolecular Med       Date:  2012-02-10       Impact factor: 3.843

3.  Multipoint linkage analysis with many multiallelic or dense diallelic markers: Markov chain-Monte Carlo provides practical approaches for genome scans on general pedigrees.

Authors:  Ellen M Wijsman; Joseph H Rothstein; Elizabeth A Thompson
Journal:  Am J Hum Genet       Date:  2006-09-20       Impact factor: 11.025

4.  Consistently replicating locus linked to migraine on 10q22-q23.

Authors:  Verneri Anttila; Dale R Nyholt; Mikko Kallela; Ville Artto; Salli Vepsäläinen; Eveliina Jakkula; Annika Wennerström; Päivi Tikka-Kleemola; Mari A Kaunisto; Eija Hämäläinen; Elisabeth Widén; Joseph Terwilliger; Kathleen Merikangas; Grant W Montgomery; Nicholas G Martin; Mark Daly; Jaakko Kaprio; Leena Peltonen; Markus Färkkilä; Maija Wessman; Aarno Palotie
Journal:  Am J Hum Genet       Date:  2008-05       Impact factor: 11.025

5.  NOS1AP in schizophrenia.

Authors:  Linda M Brzustowicz
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

6.  Revisiting schizophrenia linkage data in the NIMH Repository: reanalysis of regularized data across multiple studies.

Authors:  Veronica J Vieland; Kimberly A Walters; Thomas Lehner; Marco Azaro; Kathleen Tobin; Yungui Huang; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

7.  Novel rank-based approaches for discovery and replication in genome-wide association studies.

Authors:  Chia-Ling Kuo; Dmitri V Zaykin
Journal:  Genetics       Date:  2011-07-29       Impact factor: 4.562

8.  DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Gregory J Burrell; Aaron J Krasner; Daniel B Schwartz; Pablo V Gejman
Journal:  Hum Hered       Date:  2007-05-02       Impact factor: 0.444

9.  Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.

Authors:  Hader A Mansour; Michael E Talkowski; Joel Wood; Kodavali V Chowdari; Lora McClain; Konasale Prasad; Debra Montrose; Andrea Fagiolini; Edward S Friedman; Michael H Allen; Charles L Bowden; Joseph Calabrese; Rif S El-Mallakh; Michael Escamilla; Stephen V Faraone; Mark D Fossey; Laszlo Gyulai; Jennifer M Loftis; Peter Hauser; Terence A Ketter; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra Patel; Gary S Sachs; Pamela Sklar; Jordan W Smoller; Nan Laird; Matcheri Keshavan; Michael E Thase; David Axelson; Boris Birmaher; David Lewis; Tim Monk; Ellen Frank; David J Kupfer; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Bipolar Disord       Date:  2009-11       Impact factor: 6.744

10.  Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms.

Authors:  P A Holmans; B Riley; A E Pulver; M J Owen; D B Wildenauer; P V Gejman; B J Mowry; C Laurent; K S Kendler; G Nestadt; N M Williams; S G Schwab; A R Sanders; D Nertney; J Mallet; B Wormley; V K Lasseter; M C O'Donovan; J Duan; M Albus; M Alexander; S Godard; R Ribble; K Y Liang; N Norton; W Maier; G Papadimitriou; D Walsh; M Jay; A O'Neill; F B Lerer; D Dikeos; R R Crowe; J M Silverman; D F Levinson
Journal:  Mol Psychiatry       Date:  2009-02-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.